Vera Bittner
Overview
Explore the profile of Vera Bittner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
254
Citations
8857
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malick W, Choi D, Langsted A, Bittner V, Nordestgaard B, Stroes E, et al.
Eur J Prev Cardiol
. 2025 Mar;
PMID: 40043177
Low-density lipoprotein cholesterol (LDL-C) is the preeminent target for the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). Despite the expansive evidence supporting therapeutic reductions in LDL-C with statin therapy,...
2.
3.
4.
Clarkson S, Clarkson E, Nordberg M, Shirey M, Bittner V, White-Williams C
J Health Care Poor Underserved
. 2024 Nov;
35(4S):226-235.
PMID: 39584276
Heart failure (HF) is a complex and chronic condition that requires ongoing management, and in patients with adverse social determinants of health (SDOH) disease management can become challenging. Food insecurity...
5.
6.
Apple S, Clark R, Daich J, Gonzalez M, Ostfeld R, Toth P, et al.
Rev Cardiovasc Med
. 2024 Jul;
24(12):350.
PMID: 39077078
Although great progress has been made in the diagnostic and treatment options for dyslipidemias, unawareness, underdiagnosis and undertreatment of these disorders remain a significant global health concern. Growth in digital...
7.
Colantonio L, Wang Z, Jones J, Dhalwani N, Shannon E, Liu C, et al.
JACC Adv
. 2024 Jun;
3(1):100753.
PMID: 38939806
Background: Low-density lipoprotein cholesterol (LDL-C) is used to guide lipid-lowering therapy after a myocardial infarction (MI). Lack of LDL-C testing represents a missed opportunity for optimizing therapy and reducing cardiovascular...
8.
Khan S, Lone A, Kleiman N, Arshad A, Jain V, Al Rifai M, et al.
JACC Adv
. 2024 Jun;
2(2):100197.
PMID: 38938315
Background: The effects of aspirin in adults without atherosclerotic cardiovascular disease (ASCVD), stratified by statin use across different ASCVD risks, remain uncertain. Objectives: The purpose of this study was to...
9.
Ranasinghe S, Jain A, Taha Y, Handberg E, Johnson B, Bittner V, et al.
Am Heart J Plus
. 2024 Jun;
43:100411.
PMID: 38873103
Background: Women have smaller coronary size than men independent of body surface area. Female to male heart transplantation demonstrates coronary lumen enlargement. Purpose: To investigate relationships between endogenous androgens and...
10.
Muntner P, Ghazi L, Jones J, Dhalwani N, Poudel B, Wen Y, et al.
Adv Ther
. 2024 May;
41(6):2399-2413.
PMID: 38691317
Introduction: The cardiovascular disease risk reduction benefits of proprotein convertase subtilisin/kexin type 9 inhibitor monoclonal antibodies (PCSK9i mAb) and ezetimibe are dependent on remaining on treatment and being persistent and...